Sciatica Treatment Market Size, Share, Analysis Report

Sciatica is a state where pain causes, which travels along the path of the sciatic nerve and leads to pain in the back, buttocks, and legs. The pain commonly begins in the lower spine, and goes through the hip and buttock and down the back of the leg to the foot. Symptoms of sciatica specifically are the lower back pain, or tingling, numbness, or weakness in the leg. Even though sciatica pain can be extreme, most people find their symptoms increase with time. The incidence of sciatica is surging because of several factors such as obesity, inactive lifestyle, aging population, and injuries. As the prevalence of the condition increases, there is a corresponding rise in the demand for sciatica treatment options. Thus, the rise in the prevalence significantly driving the sciatica treatment market growth. On the other hand, the possible side effects of the treatment of sciatica may hamper the market growth.

The Sciatica Treatment Market is expected to be around US$ 8000 Million by 2028 at a CAGR 4.6%.

The Sciatica Treatment Market has been segmented as below:

Sciatica Treatment Market based on Type        

• Acute sciatica
• Chronic sciatica
• Others

Sciatica Treatment Market based on Drug class          

• Non-steroidal anti-inflammatory drugs
• Steroids
• Antidepressants
• Others

Sciatica Treatment Market based on Distribution channel  

• Hospital pharmacies
• Retail and specialty pharmacies
• Online providers

Sciatica Treatment Market based on Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

On the basis of type, the market is furcated into Acute Sciatica, Chronic Sciatica and Others. Compared to other types, the chronic sciatica segment is projected to have the major share in the market. This is because of rise in incidence of chronic sciatica, combined with transformations in human lifestyle and rise in cases of spine tumor and herniated disc.

Further in the market for drug class, the market is segmented as Non-steroidal anti-inflammatory drugs, Steroids, Antidepressants and Others. The Non-steroidal anti-inflammatory drugs type segment is having the largest share in the market growth. The affordable cost and easy availability of non-steroidal anti-inflammatory drugs as over the counter drug is the key reason for segment growth. Moreover, the non-steroidal anti-inflammatory drugs are regularly prescribed by the healthcare provider for people with acute sciatica.

The market based on Distribution channel is divided into Hospital pharmacies, Retail and specialty pharmacies and Online Providers. In this segmentation the Retail and specialty pharmacies segment to hold the significant share in the market. This is because of its large chain of distribution networks, innovative marketing strategies, and offer better financial & debt management to the patients.

Among North America, Europe, Asia Pacific and rest of the world the North America region has the major share in the market on the basis of geography. The major share is ascribed to the presence of number of key players in the nation and advancement in manufacturing technology.

One of the key drivers in the global market growth is that there is a surging awareness regarding sciatica among patients, healthcare professionals, and the general public. This has resulted in a rise in the number of patients looking for diagnosis and treatment for the condition, eventually propelling the growth of the global sciatica treatment market.

Key players operating in the market include Zydus Lifesciences Limited, Sorrento Therapeutics, Inc, Amneal Pharmaceuticals LLC, Abbott Laboratories, Teva Pharmaceutical Industries Limited, Aurobindo Pharma, Alkem Laboratories Ltd, Johnson and Johnson, Sun Pharmaceutical Industries Ltd., and Sinfonia Biotherapeutics.

Therefore, the sciatica treatment market is projected to continue to augment in the coming years owing to these drivers, among others. The rising prevalence of the condition and the rising demand for non-invasive treatments are projected to be the key drivers of market growth.

• Complete information on factors is provided which will propel sciatica treatment market growth in the forecast period.
• This report gives the exact estimation of the market size and its contribution to the parent market along with the precise estimation on upcoming trends and shifts in consumer behavior.
• This research provides growth analysis of the market among regions such as North America, Europe, Asia Pacific and rest of the world.
• This report further provides comprehensive details of factors which will challenge the growth of market players.